# Heparin or Enoxaparin in Patients With Cancer

> **NCT00004875** · — · COMPLETED · sponsor: **Northwestern University** · enrollment: 6 (actual)

## Conditions studied

- Lymphoma
- Thromboembolism
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** enoxaparin
- **DRUG:** heparin

## Key facts

- **NCT ID:** NCT00004875
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 1996-07
- **Primary completion:** 1999-03
- **Final completion:** 1999-03
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2011-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004875, "Heparin or Enoxaparin in Patients With Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00004875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*